NewHold Investment Corp. III Sets Sept. 17 Vote on Newcleo Merger

What happened

NewHold Investment Corp. III, a blank-check company listed on Nasdaq under the ticker NHIC, filed a definitive proxy statement/prospectus on August 10, 2026, according to the SEC filing. The filing sets a shareholder meeting for 9:00 a.m. Eastern Time on September 17, 2026, at the offices of Loeb & Loeb LLP in New York and by live webcast.

Shareholders are being asked to approve the company's previously announced business combination with NewCleo Ltd., a private UK company developing nuclear technology, along with related proposals. The NewHold board has recommended shareholders vote for the business combination proposal, the merger proposal and an adjournment proposal if one is presented.

Under the merger structure, NewHold will merge into a subsidiary of Newcleo, and NewHold shareholders will receive ordinary shares of Newcleo. NewHold units will separate automatically into one Class A ordinary share and one-half of a warrant, and each outstanding NewHold share will be cancelled in exchange for one newly issued Newcleo ordinary share. Each NewHold warrant will be exchanged for a Newcleo warrant.

Newcleo has agreed to sell 22,000,000 shares at $10.00 each — $220,000,000 in total — to investors in a private investment in public equity, or PIPE. A condition of the deal is that at least $200,000,000 in cash, before fees and expenses, comes from NewHold's trust account plus the PIPE. The proxy states Newcleo will apply to list its ordinary shares on Nasdaq under the symbol "NWCL" once the deal closes.

The filing also describes non-redemption agreements under which certain shareholders agreed not to redeem up to 923,780 NewHold Class A shares, in exchange for which the sponsor agreed to forfeit 92,378 Class B shares at closing and assign those investors an equivalent number of Newcleo shares.

The numbers in the deal

The proxy states Newcleo's base equity value at $2,350,000,000, plus the exercise price of vested options and any pre-closing equity financing proceeds.

Before the merger, Newcleo will restructure its capital: reduce its share premium account, re-register as a UK public limited company, redenominate its shares in US dollars, and consolidate its shares by a factor derived from the base equity value. The filing gives an estimated recapitalization factor of 0.4807, meaning the share count is roughly halved.

After closing, Newcleo shareholders are expected to hold 244,883,387 ordinary shares. The proxy models three outcomes based on how many NewHold public shareholders ask for their money back instead of taking merger shares. With no redemptions, existing Newcleo holders would own about 81.5% of the company and NewHold public shareholders about 6.7%. If all public shares are redeemed, Newcleo holders would own about 87.1% and public shareholders about 0.3%.

The stock closed at $10.62 on the event date, unchanged from the prior close, according to the price data.

What this means

NewHold Investment Corp. III is a special purpose acquisition company, or SPAC — a shell company with no operating business that raises money in an initial public offering and lists on an exchange with the sole purpose of finding a private company to merge with. Until it finds a target, its IPO proceeds sit in a trust account earning interest. The company name carries the "(Blank Checks)" label in the detection system for exactly this reason.

A DEFM14A — definitive proxy statement — is the final version of the document a company must file with the SEC before asking shareholders to vote on a matter requiring their approval. "Definitive" means the document is final and can be used to solicit votes, as opposed to a preliminary proxy, which is a draft filed for SEC review. It is accompanied here by a prospectus, because the shares being issued to NewHold shareholders and to PIPE investors must be registered under the Securities Act. The combined proxy/prospectus serves two legal obligations at once: it tells NewHold shareholders what they are voting on, and it registers the Newcleo shares they will receive.

The mechanics of the vote matter to a non-specialist. If shareholders approve the deal, NewHold stops existing as an independent public company, its shares are cancelled, and holders receive Newcleo shares in their place. Because Newcleo is not currently a public reporting company, the merger is how it becomes one: after closing, it will be subject to the Exchange Act's periodic reporting requirements and its shares will trade under a new ticker, NWCL, on the same exchange.

Redemption rights are the other piece of the machinery. SPAC shareholders get to vote for or against a deal and separately demand the return of their IPO money from the trust account, which is why the proxy presents ownership tables under "No Redemptions," "Intermediate (50%) Redemptions" and "Maximum (100%) Redemptions." The PIPE is what backstops that: $220,000,000 in committed cash to ensure the company has at least $200,000,000 to work with when the deal closes, regardless of how many shareholders cash out.

The warrant exchange works on the same principle. NewHold warrants currently give holders the right to buy NewHold Class A shares at a set price. At closing, they are terminated and replaced with Newcleo warrants on the same economic terms, so holders retain the option rather than losing it when the shell company disappears.

The filing does not state why NewHold and Newcleo chose to combine, nor why the deal terms were set as they were. It describes what will happen and on what conditions.